AUPP332898A0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
AUPP332898A0
AUPP332898A0 AUPP3328A AUPP332898A AUPP332898A0 AU PP332898 A0 AUPP332898 A0 AU PP332898A0 AU PP3328 A AUPP3328 A AU PP3328A AU PP332898 A AUPP332898 A AU PP332898A AU PP332898 A0 AUPP332898 A0 AU PP332898A0
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP3328A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unisearch Ltd
Original Assignee
Unisearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unisearch Ltd filed Critical Unisearch Ltd
Priority to AUPP3328A priority Critical patent/AUPP332898A0/en
Publication of AUPP332898A0 publication Critical patent/AUPP332898A0/en
Priority to AU35125/99A priority patent/AU765846B2/en
Priority to HK02105428.9A priority patent/HK1044117B/zh
Priority to EP99916716A priority patent/EP1124557A4/en
Priority to CNB998081574A priority patent/CN1204893C/zh
Priority to KR1020007012271A priority patent/KR20010052305A/ko
Priority to JP2000546727A priority patent/JP2002513733A/ja
Priority to PCT/AU1999/000323 priority patent/WO1999056697A2/en
Priority to ZA200006953A priority patent/ZA200006953B/en
Priority to US09/861,865 priority patent/US6664246B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AUPP3328A 1998-05-04 1998-05-04 Pharmaceutical composition Abandoned AUPP332898A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AUPP3328A AUPP332898A0 (en) 1998-05-04 1998-05-04 Pharmaceutical composition
PCT/AU1999/000323 WO1999056697A2 (en) 1998-05-04 1999-05-04 Pharmaceutical composition
CNB998081574A CN1204893C (zh) 1998-05-04 1999-05-04 药物组合物
HK02105428.9A HK1044117B (zh) 1998-05-04 1999-05-04 藥物組合物
EP99916716A EP1124557A4 (en) 1998-05-04 1999-05-04 Pharmaceutical composition
AU35125/99A AU765846B2 (en) 1998-05-04 1999-05-04 Pharmaceutical composition
KR1020007012271A KR20010052305A (ko) 1998-05-04 1999-05-04 약제 조성물
JP2000546727A JP2002513733A (ja) 1998-05-04 1999-05-04 医薬組成物
ZA200006953A ZA200006953B (en) 1998-05-04 2000-11-27 Pharmaceutical composition.
US09/861,865 US6664246B2 (en) 1998-05-04 2001-05-22 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP3328A AUPP332898A0 (en) 1998-05-04 1998-05-04 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
AUPP332898A0 true AUPP332898A0 (en) 1998-05-28

Family

ID=3807582

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP3328A Abandoned AUPP332898A0 (en) 1998-05-04 1998-05-04 Pharmaceutical composition

Country Status (9)

Country Link
US (1) US6664246B2 (enExample)
EP (1) EP1124557A4 (enExample)
JP (1) JP2002513733A (enExample)
KR (1) KR20010052305A (enExample)
CN (1) CN1204893C (enExample)
AU (1) AUPP332898A0 (enExample)
HK (1) HK1044117B (enExample)
WO (1) WO1999056697A2 (enExample)
ZA (1) ZA200006953B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087350A (en) 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
US7129230B2 (en) * 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
US20050038022A1 (en) * 2001-03-26 2005-02-17 Unisearch Limited Method for treatment of cancer and compositions for use therein
AUPR644301A0 (en) * 2001-07-17 2001-08-09 Unisearch Limited Method and composition for treatment of cancer
US20050209551A1 (en) * 2004-03-18 2005-09-22 Takemoto Arnold C Detoxification and breast health preparations
CA2558202A1 (en) * 2006-09-14 2006-11-23 Reinhold W. Vieth Vitamin d compositions and method of administration to infants
ITMI20121041A1 (it) 2012-06-15 2013-12-16 Lga Biotecnologie S R L Chemioprevenzione del cancro del colon - retto
CN106109476A (zh) * 2016-06-13 2016-11-16 中山大学 骨化二醇作为吲哚胺2,3‑双加氧酶‑1抑制剂的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260067A (en) * 1988-11-16 1993-11-09 Xu Zheng Cytotropic heterogeneous molecular lipids (CHML) and process for preparing the same
US5798345A (en) * 1990-09-21 1998-08-25 Bone Care International, Inc. Method of inhibiting the hyperproliferation of malignant cells
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
EP0619305B1 (en) * 1993-02-05 1997-06-04 Teijin Limited Lactone compound and process of producing thereof
AUPO727097A0 (en) * 1997-06-10 1997-07-03 Unisearch Limited Method of treatment of hepatoma and pharmaceutical compositions for use therein
CN1090180C (zh) * 1997-06-25 2002-09-04 帝人株式会社 维生素d3衍生物及其用于炎性呼吸道疾病的治疗剂

Also Published As

Publication number Publication date
WO1999056697A2 (en) 1999-11-11
WO1999056697A3 (en) 2001-06-21
EP1124557A4 (en) 2002-08-07
CN1204893C (zh) 2005-06-08
EP1124557A2 (en) 2001-08-22
US20020128239A1 (en) 2002-09-12
KR20010052305A (ko) 2001-06-25
HK1044117A1 (en) 2002-10-11
CN1332629A (zh) 2002-01-23
HK1044117B (zh) 2005-10-21
JP2002513733A (ja) 2002-05-14
US6664246B2 (en) 2003-12-16
ZA200006953B (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU6740298A (en) Pharmaceutical composition
AU4413299A (en) Stabilized pharmaceutical compositions
AU4762797A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
PT1466615E (pt) Composição farmacêutica
PL343769A1 (en) Pharmaceutical composition
AU1290501A (en) Composition
AU1887401A (en) Medicinal composition
AU8107998A (en) Pharmaceutical compositions
AU3777897A (en) Pharmaceutical compositions
GB9818591D0 (en) Pharmaceutical composition
AU4326197A (en) Pharmaceutical compositions
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU9343098A (en) Pharmaceutical composition
AUPP332898A0 (en) Pharmaceutical composition
AU6480299A (en) Pharmaceutical compounds
AU1688099A (en) Pharmaceutical preparation
AU5182099A (en) Pharmaceutical formulation
AU4914400A (en) Novel pharmaceutical composition
AU2087897A (en) Pharmaceutical compositions
AU4457597A (en) Pharmaceutical compositions
AU5184599A (en) Pharmaceutical compounds
AU2279800A (en) Pharmaceutical preparation
AU2648899A (en) Composition